Impact of regulatory interventions to restrict the combined use of renin-angiotensin system-acting agents in Denmark: interrupted time series analysis

22/12/2020
11/01/2022
EU PAS number:
EUPAS38752
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

DUS of RAS-acting agents

English (377.41 KB - PDF) View document
Study results
Study results

Impact of regulatory interventions to restrict the combined use of renin-angiotensin system blockers

English (574.59 KB - PDF) View document
Study report
Other information